Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma

Blanca Sanchez-GonzalezDepartment of Hematology, Hospital del Mar – IMIM, Barcelona, SpainCorrespondence[email protected]

Eva GimenoDepartment of Hematology, Hospital del Mar – IMIM, Barcelona, Spain

Francesc Garcia-PallarolsDepartment of Hematology, Hospital del Mar – IMIM, Barcelona, Spain

Agueda AncocheaDepartment of Hematology, Hospital del Mar – IMIM, Barcelona, Spain

Antonio SalarDepartment of Hematology, Hospital del Mar – IMIM, Barcelona, Spain

References

Salles G, Seymour JF, Offner F, et al. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. Lancet 2011;377:42–51.
PubMed Web of Science ®Google Scholar
Kluin-Nelemans HC, Hoster E, Hermine O, et al. Treatment of older patients with mantle-cell lymphoma. N Engl J Med 2012;367: 520–531.
PubMed Web of Science ®Google Scholar
van Oers MH, Van Glabbeke M, Giurgea L, et al. Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study. J Clin Oncol 2010;28:2853–2858.
PubMed Web of Science ®Google Scholar
Hainsworth JD, Litchy S, Burris HA 3rd, et al. Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma. J Clin Oncol 2002;20:4261–4267.
PubMed Web of Science ®Google Scholar
Cheson BD, Pfistner B, Juweid ME, et al. International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date